Steven J Mottola
Examiner (ID: 17760, Phone: (571)272-1766 , Office: P/2842 )
Most Active Art Unit | 2817 |
Art Unit(s) | 2515, 2842, 2843, 2817, 2502, 2607, 3621 |
Total Applications | 3603 |
Issued Applications | 3334 |
Pending Applications | 99 |
Abandoned Applications | 170 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5929813
[patent_doc_number] => 20110039772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'NOVEL USES OF VEGFXXXB'
[patent_app_type] => utility
[patent_app_number] => 12/918363
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7778
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039772.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918363 | NOVEL USES OF VEGFXXXB | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5404449
[patent_doc_number] => 20090239763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'MARKERS FOR BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/370972
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 34881
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370972
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370972 | Markers for breast cancer | Feb 12, 2009 | Issued |
Array
(
[id] => 6034633
[patent_doc_number] => 20110082549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'MINERALIZED THREE-DIMENSIONAL BONE CONSTRUCTS FORMED FROM OSTEOBLASTS'
[patent_app_type] => utility
[patent_app_number] => 12/865568
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8607
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082549.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865568
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865568 | MINERALIZED THREE-DIMENSIONAL BONE CONSTRUCTS FORMED FROM OSTEOBLASTS | Feb 1, 2009 | Abandoned |
Array
(
[id] => 5397343
[patent_doc_number] => 20090317406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Phosphorylation of tau by abl'
[patent_app_type] => utility
[patent_app_number] => 12/319283
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7157
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319283 | Phosphorylation of tau by abl | Jan 4, 2009 | Abandoned |
Array
(
[id] => 6195494
[patent_doc_number] => 20110027248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Sugar Chain-Related Gene and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/809969
[patent_app_country] => US
[patent_app_date] => 2008-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 36648
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027248.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809969 | Sugar Chain-Related Gene and Use Thereof | Dec 25, 2008 | Abandoned |
Array
(
[id] => 6038475
[patent_doc_number] => 20110091524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'BIOMARKERS FOR SENSITIVITY TO ANTI-IGF1R THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/808270
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36379
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091524.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808270
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808270 | BIOMARKERS FOR SENSITIVITY TO ANTI-IGF1R THERAPY | Dec 16, 2008 | Abandoned |
Array
(
[id] => 6623674
[patent_doc_number] => 20100311159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'METHODS FOR PURIFYING OR DEPLETING MOLECULES OR CELLS OF INTEREST'
[patent_app_type] => utility
[patent_app_number] => 12/808679
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8151
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808679
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808679 | METHODS FOR PURIFYING OR DEPLETING MOLECULES OR CELLS OF INTEREST | Dec 16, 2008 | Abandoned |
Array
(
[id] => 9762560
[patent_doc_number] => 08846886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Lepidopteran insect N-acetylglucosaminidase genes and their use in glycoengineering'
[patent_app_type] => utility
[patent_app_number] => 12/746808
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18586
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746808 | Lepidopteran insect N-acetylglucosaminidase genes and their use in glycoengineering | Dec 11, 2008 | Issued |
Array
(
[id] => 6348829
[patent_doc_number] => 20100248971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'PROCESS FOR ANTIBODY PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/745876
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 15837
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20100248971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745876 | PROCESS FOR ANTIBODY PRODUCTION | Dec 2, 2008 | Abandoned |
Array
(
[id] => 9153916
[patent_doc_number] => 08586822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Methods for producing a non human model for aortic aneurysm'
[patent_app_type] => utility
[patent_app_number] => 12/740405
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9525
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740405
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740405 | Methods for producing a non human model for aortic aneurysm | Sep 29, 2008 | Issued |
Array
(
[id] => 9922331
[patent_doc_number] => 08980287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination'
[patent_app_type] => utility
[patent_app_number] => 12/237787
[patent_app_country] => US
[patent_app_date] => 2008-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 5554
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12237787
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/237787 | Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination | Sep 24, 2008 | Issued |
Array
(
[id] => 4949020
[patent_doc_number] => 20080305146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'SELECTIVE CELL THERAPY FOR THE TREATMENT OF RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/134813
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 9151
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12134813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/134813 | SELECTIVE CELL THERAPY FOR THE TREATMENT OF RENAL FAILURE | Jun 5, 2008 | Pending |
Array
(
[id] => 6459972
[patent_doc_number] => 20100190204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Detection and Identification of Microorganisms on Transparent Permeable Membranes'
[patent_app_type] => utility
[patent_app_number] => 12/532501
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8651
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190204.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532501
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532501 | Detection and Identification of Microorganisms on Transparent Permeable Membranes | Mar 23, 2008 | Abandoned |
Array
(
[id] => 6631501
[patent_doc_number] => 20100173295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'FIXATION OF A BIOLOGICAL MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 12/528719
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16099
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173295.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528719 | FIXATION OF A BIOLOGICAL MATERIAL | Feb 26, 2008 | Abandoned |
Array
(
[id] => 6520086
[patent_doc_number] => 20100203110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production'
[patent_app_type] => utility
[patent_app_number] => 12/519957
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24061
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203110.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519957 | Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production | Dec 16, 2007 | Abandoned |
Array
(
[id] => 4752541
[patent_doc_number] => 20080160616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/797219
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 22467
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20080160616.pdf
[firstpage_image] =>[orig_patent_app_number] => 11797219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/797219 | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof | Apr 30, 2007 | Abandoned |
Array
(
[id] => 5270961
[patent_doc_number] => 20090074737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS'
[patent_app_type] => utility
[patent_app_number] => 12/089132
[patent_app_country] => US
[patent_app_date] => 2006-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 28154
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074737.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089132 | COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS | Oct 15, 2006 | Abandoned |
Array
(
[id] => 5270961
[patent_doc_number] => 20090074737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS'
[patent_app_type] => utility
[patent_app_number] => 12/089132
[patent_app_country] => US
[patent_app_date] => 2006-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 28154
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074737.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089132 | COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS | Oct 15, 2006 | Abandoned |
Array
(
[id] => 10506953
[patent_doc_number] => 09234823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Method and apparatus for handling tissue samples'
[patent_app_type] => utility
[patent_app_number] => 12/066013
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 25
[patent_no_of_words] => 5880
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12066013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066013 | Method and apparatus for handling tissue samples | Sep 5, 2006 | Issued |
Array
(
[id] => 5608526
[patent_doc_number] => 20060270042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'High-titer retroviral packaging cells'
[patent_app_type] => utility
[patent_app_number] => 11/431824
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5670
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431824 | High-titer retroviral packaging cells | May 10, 2006 | Abandoned |